Aurothioglucose
250px | |
250px | |
Systematic (IUPAC) name | |
---|---|
gold(I) (2S,3S,4R,5S)-3,4,5-trihydroxy-
6-(hydroxymethyl)-oxane-2-thiolate |
|
Clinical data | |
AHFS/Drugs.com | Consumer Drug Information |
Routes of administration |
Intramuscular injection |
Pharmacokinetic data | |
Bioavailability | 0% |
Identifiers | |
CAS Number | 12192-57-3 ![]() |
ATC code | M01CB04 (WHO) |
PubChem | CID: 6104 |
ChemSpider | 16738764 ![]() |
UNII | 2P2V9Q0E78 ![]() |
ChEMBL | CHEMBL1697725 ![]() |
Synonyms | Gold thioglucose, Solganal, Auromyose |
Chemical data | |
Formula | C6H11AuO5S |
Molecular mass | 392.181 g/mol |
|
|
|
|
![]() ![]() |
Aurothioglucose, also known as gold thioglucose, is a chemical compound with the formula AuSC6H11O5. This derivative of the sugar glucose was formerly used to treat rheumatoid arthritis.
Contents
History
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
Throughout history, gold was used to cure diseases, although the efficacy was not established. In 1935, gold drugs were reported to be effective for the treatment of rheumatoid arthritis.[1] Although many patients reacted positively to the drug, gold thioglucose was not uniformly effective.
Three gold drugs remain in active clinical use for this purpose in the United States: auranofin, sodium aurothiomalate (gold sodium thiomalate) and aurothioglucose. In the United Kingdom, only sodium aurothiomalate and auranofin are used.
In 2001, aurothoglucose was withdrawn from the Dutch marked, where it had been the only injectable gold preparation available since 1943, forcing hospitals to change medication for a large number of patients to aurothiomalate.[2] The drug had been in use for more than 70 years, and four years later the reasons for its sudden disappearance remained unclear.[3]
Medicinal chemistry
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
Gold thioglucose features gold in the oxidation state of +I, like other gold thiolates. It is a water-soluble, non-ionic species that is assumed to exist as a polymer.[1] Under physiological conditions, an oxidation-reduction reaction leads to the formation of metallic gold and sulfinic acid derivative of thioglucose.
- 2 AuSTg → 2 Au + TgSSTg
- TgSSTg + H2O → TgSOH + TgSH
- 2 TgSOH → TgSO2H + TgSH
- Overall: 2 H2O + 4 AuSTg → 4 Au + TgSO2H + 3 TgSH
(where AuSTg = gold thioglucose, TgSSTg = thioglucose disulfide, TgSO2H = sulfinic acid derivative of thioglucose)
Preparation
Gold thioglucose can be prepared by treating gold bromide with thioglucose solution saturated with sulfur dioxide. Gold thioglucose is precipitated with methanol and recrystallized with water and methanol.
Miscellaneous observations
In recent research, it was found that injection of gold thioglucose in the mouse induces obesity.[4] Aurothioglucose has an interaction with the antimalarial medication hydroxychloroquine.
See also
References
- ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate (van Roon et al, J Rheumatol 2005)
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
Media related to Lua error in package.lua at line 80: module 'strict' not found. at Wikimedia Commons
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Gold compounds
- IARC Group 3 carcinogens
- Coordination compounds
- Antirheumatic products
- Organosulfur compounds